CN104397538A - Health-care diet food - Google Patents
Health-care diet food Download PDFInfo
- Publication number
- CN104397538A CN104397538A CN201410786206.1A CN201410786206A CN104397538A CN 104397538 A CN104397538 A CN 104397538A CN 201410786206 A CN201410786206 A CN 201410786206A CN 104397538 A CN104397538 A CN 104397538A
- Authority
- CN
- China
- Prior art keywords
- weight
- health
- fat
- contents
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title abstract description 12
- 235000005911 diet Nutrition 0.000 title abstract description 5
- 230000037213 diet Effects 0.000 title abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 26
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 19
- 229940094952 green tea extract Drugs 0.000 claims abstract description 19
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 10
- 239000000944 linseed oil Substances 0.000 claims abstract description 10
- 235000013871 bee wax Nutrition 0.000 claims abstract description 8
- 235000013402 health food Nutrition 0.000 claims description 19
- 241000202807 Glycyrrhiza Species 0.000 claims description 18
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 16
- 229940010454 licorice Drugs 0.000 claims description 16
- 239000003292 glue Substances 0.000 claims description 12
- 239000012166 beeswax Substances 0.000 claims description 6
- -1 phosphatide Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 26
- 239000007901 soft capsule Substances 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 8
- 208000008589 Obesity Diseases 0.000 abstract description 7
- 235000020824 obesity Nutrition 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 7
- 206010010774 Constipation Diseases 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 2
- 150000003904 phospholipids Chemical class 0.000 abstract 2
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 abstract 1
- 229940108924 conjugated linoleic acid Drugs 0.000 abstract 1
- 229940069445 licorice extract Drugs 0.000 abstract 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 22
- 241001465754 Metazoa Species 0.000 description 19
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000000306 component Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 9
- 229960004949 glycyrrhizic acid Drugs 0.000 description 9
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 9
- 235000019410 glycyrrhizin Nutrition 0.000 description 9
- 210000000577 adipose tissue Anatomy 0.000 description 8
- 235000013339 cereals Nutrition 0.000 description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 239000001685 glycyrrhizic acid Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004378 Glycyrrhizin Substances 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 238000002485 combustion reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 206010033307 Overweight Diseases 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008157 edible vegetable oil Substances 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 2
- 235000020997 lean meat Nutrition 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-MOGLOQIBSA-N (2s,3s,4s,5r,6r)-6-[(2r,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-c Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-MOGLOQIBSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to health-care diet food which comprises a soft capsule body and contents, wherein the contents comprise components in percentage by weight as follows: 6%-14% of conjugated linoleic acid, 7%-18% of lycium barbarum polysaccharide, 12%-19% of a licorice extract, 10%-22% of a green tea extract, and 30%-65% of auxiliary materials; and the auxiliary materials comprise flaxseed oil, phospholipid and beewax, the flaxseed oil accounts for 22%-57% of the weight of contents, the phospholipid accounts for 2%-7% of the weight of contents, and the beewax accounts for 2%-7% of the weight of contents. The health-care diet food has simple and reasonable raw material composition, natural ingredients, appropriate matching, convenience in taking and obvious diet effects, does not have obvious side effects and is green and health-care food for patients suffering from hyperlipidemia, constipation and obesity.
Description
Technical field
The invention belongs to health food research and development field, specifically a kind of slimming health food.
Background technology
When obesity become serious problem threaten the health of the mankind, review fat root, the main or problem of diet.And obesity also brings the disease of other threat human healths a lot, as hypertension, coronary heart disease etc., the worry that obesity brings grows with each passing day, although ways of preventing obesity is multifarious, result is not the object not reaching fat-reducing, causes a lot of bad reaction exactly.According to investigations, China at present population of being obese reaches 3.25 hundred million people, has 17% to be overweight people in China's urban population, and the children of China have 51% to be overweight people.The portion that the World Health Organization delivers is reported, the sharp increase in 20 years of going of global population of being obese, the whole world has 1,000,000,000 Genus Homos in overweight people.Obesity easily causes metabolism and endocrine disturbance, and with illness such as diabetes, atherosclerotic, high fat of blood, hypertension, therefore, weight losing function food has very large potentiality to be exploited.At present, market has the Western medicine of many fat-reducing, reducing blood lipid, hypoglycemic, defaecation, the treatment for above-mentioned symptom truly has curative effect, but long-term taking exists the large deficiency of side effect.Traditional Chinese medicine for losing weight mainly through promoting that excretion achieves the goal, but has certain injury to digestion excretory system.
In recent years, l-cn is widely used in various health food, such as the applicant discloses a kind of weight-losing soft capsules and preparation method thereof at first patent application ZL201110100237.3, weighs content CLA 60% ~ 80%, l-cn 5 ~ 15%, green-tea extract 5 ~ 15%, konjaku flour 1 ~ 10%, blueberry extract 1 ~ 10% by weight percentage.It adopts CLA, green-tea extract, l-cn to prepare slimming health food as primary raw material.In cell, the basic function of l-cn, just as carrier, is transported outward aliphatic acid into mitochondrial inner membrane from mitochondria, oxidized and give off energy in mitochondria lactones fat acid.If amount of exercise is little, fat consumption is few, just increases l-cn, can't increase the oxidative function of fat.Only when amount of exercise is larger, take l-cn and just contribute to fat-reducing.Therefore, for inapplicable the little fat-reducing people of amount of exercise at ordinary times.
In addition, the applicant also discloses at first patent application 201310587420.X a kind ofly has health food of toxin expelling weight losing function and preparation method thereof, its be choose pueraria root powder 10 ~ 20% by weight percentage, konjaku flour 10 ~ 30%, aloe powder 10 ~ 20%, grape seed extract 5 ~ 10%, haw thorn extract 5 ~ 15%, Auricularia extract 5 ~ 15% be primary raw material, be aided with the auxiliary material 0 ~ 45% that health food allows and make tablet, soft capsule, capsule or granule.This health food component is more, and cost is higher.
Summary of the invention
Technical problem to be solved by this invention overcomes above-mentioned the deficiencies in the prior art, and provide a kind of raw material to form simple, reasonable, composition is natural, and proportioning is appropriate, taking convenience, and effect of weight reducing is obvious, the slimming health food of non-evident effect.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of slimming health food, be made up of flexible glue utricule and content, it is characterized in that: described content is made up of CLA, LBP-X, licorice, green-tea extract, auxiliary material, the percentage by weight of each component is: CLA 6%-14%, LBP-X 7%-18%, licorice 12%-19%, green-tea extract 10%-22%, auxiliary material 30%-65%.
Further preferred version is, the percentage by weight of each component of described content is: CLA 10%, LBP-X 13%, licorice 16%, green-tea extract 12%, auxiliary material 49%.
Further, described auxiliary material is made up of linseed oil, phosphatide, beeswax, and the percentage by weight of described linseed oil in content is 22%-57%, and phosphatide is 2%-7%, and beeswax is 2%-7%.
CLA of the present invention (CLA) is a series of double bond linoleic acid, there is scavenging free radicals, strengthen oxidation resistance and the immunocompetence of human body, promote that fat oxidation decomposes, promote human body protein synthesis, human body is carried out to the effects such as comprehensive optimum adjustment.LBP-X (LBP) has reducing blood lipid, hypoglycemic effect, can significantly improve the active quantities of superoxide dismutase (SOD) of body blood, liver and muscular tissue, be conducive to the removing of active oxygen, delay senility and antifatigue.In green-tea extract, its functional component polyphenol content reaches more than 60%, has strong non-oxidizability and physiologically active, is the scavenger of human free radical.In licorice, main component comprises: glycyrrhizin, glycyrrhizic acid, and liquiritin, flavonoids of Glycyrrhiza, Quercetin etc., have stronger antioxidation activity, can promote the combustion decomposition of fat.The present invention has synergy when each constituent coexists, and can promote fat combustion and energy ezpenditure, reaches the object of lipopenicillinase.Various ingredients all contains polyphenol and Flavonoid substances, can be combined by the polysaccharose substance in matrimony vine, the activity of inhibitory enzyme, thus suppresses microbial growth and oxidation.It is auxiliary material that the present invention chooses high-quality linseed oil, and its a large amount of leukotrienes contained, linoleic acid have powerful effect to human body, avoids negative effect such as fat accumulation, Hyperlipemia that other vegetable and animals oils are brought.
Content of the present invention is suspendible feed liquid, can be passed through batching, pelleting, drying, washes the operations such as ball and make soft capsule, produce the soft capsule slimming health food that content content is 500-750mg/ grain.Be every day 2 times by human body recommended intake, each 1-2 grain is taken.Through test, effect of weight reducing is obvious, non-evident effect, taking convenience.The present invention goes out described composition and ratio by a large amount of assay optimization, and against existing technologies, raw material composition of the present invention is simple, rationally, composition is natural, and proportioning is appropriate, taking convenience, and effect of weight reducing is obvious, non-evident effect.It is the green health care food of high fat of blood, constipation, obese patient.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
A kind of slimming health food, be made up of flexible glue utricule and content, described content is made up of CLA, LBP-X, licorice, green-tea extract, auxiliary material, the percentage by weight of each component is: CLA 6%-14%, LBP-X 7%-18%, licorice 12%-19%, green-tea extract 10%-22%, auxiliary material 30%-65%.
Further preferred version is, the percentage by weight of each component of described content is: CLA 10%, LBP-X 13%, licorice 16%, green-tea extract 12%, auxiliary material 49%.
Further, described auxiliary material is made up of linseed oil, phosphatide, beeswax; The percentage by weight of described linseed oil in content is 22%-57%, and phosphatide is 2%-7%, and beeswax is 2%-7%.
The present invention's each raw material effect is as follows: CLA (CLA) is a series of double bond linoleic acid, there is scavenging free radicals, strengthen oxidation resistance and the immunocompetence of human body, enhancing development, regulate blood cholesterol levels and triglyceride levels, atherosclerosis, promote that fat oxidation decomposes, promote human body protein synthesis, human body is carried out to the effects such as comprehensive optimum adjustment.Recently increasing Clinical Report is had all to prove, the excellent performance of CLA in body weight control, subtract " weight " because common people's fat-reducing all only can focus on but not subtract " fertilizer ", that is body fat ratio not necessarily can change, if the people of fat-reducing can coordinate the use of CLA, the ratio of body fat tissue relative to lean tissue can be effectively reduced, real reduces to fat meat, and make lean meat ratio increase, such benefit is that lean meat is more, body intracellular metabolic ability is higher, so form benign cycle, fat-reducing more easily will reach target, the slimmer of long-term taking CLA, mood is very stable, sleep and mental status also relatively good, this is just more conducive to the execution of weight loss program.
LBP-X (LBP) has reducing blood lipid, hypoglycemic effect, obvious humidification is had to hemopoietic function of bone marrow and every Immunological Markers for Cell-Mediated Immunity, the active quantities of superoxide dismutase (SOD) of body blood, liver and muscular tissue can be significantly improved, thus be conducive to the removing of active oxygen, delay senility and antifatigue; Increase the quantity of antibody forming cell, improve antibody effects.
Green-tea extract is commercial products, is provided by sky, Hanzhong Rangu, and its functional component polyphenol content reaches more than 60%, has very strong non-oxidizability and physiologically active, is the scavenger of human free radical.Cholesterol, the triglycerides equal size of human body are high, and blood vessel fat deposition, forms the angiocardiopathies such as atheromatous plaque after vascular smooth muscle cell curing; Catechins ECG in Tea Polyphenols, especially Tea Polyphenols and EGC and oxidation product theaflavin etc. thereof, contribute to this plaque-like hyperplasia is suppressed, and the fibrinogen that formation blood clotting viscosity is strengthened reduces, and blood coagulation becomes clear, thus suppresses atherosclerotic.
Licorice is commercial products, and provided by sky, Hanzhong Rangu, its glycyrrhizic acid content reaches more than 10%.Its main component comprises: glycyrrhizin, glycyrrhizic acid, liquiritin, flavonoids of Glycyrrhiza, Quercetin etc.Main component glycyrrhizin is wherein glycyrrhizic acid and its esters composition of extraction and isolation from Radix Glycyrrhizae, and glycyrrhizin and glycyrrhizic acid can prevent lipidosis to have animal and human's body experimental study to show, reduces blood cholesterol level.It has sugariness high (sugariness is approximately sucrose 80-300 doubly), low calorie, safety non-toxic and stronger medicinal health care function, be the most desirable sweetener of hypertension, obesity, diabetes, cardiac's use, it can make up sucrose essence and wait sweetener to bring out the drawback of above-mentioned disease.In addition, the Flavonoid substances contained in its component and Quercetin etc., have stronger antioxidation activity, can promote the combustion decomposition of fat.
Present component is natural and green-tea extract and licorice all have extremely strong non-oxidizability, when coexisting, there is synergy, fat combustion and energy ezpenditure can be promoted, reach the object of lipopenicillinase, and various ingredients all contains polyphenol and Flavonoid substances, can be combined by polysaccharose substance in matrimony vine, the activity of inhibitory enzyme, thus suppress microbial growth and oxidation.Further, the two composite bitter taste effectively can covering Radix Glycyrrhizae, adds mouthfeel.
Traditional soft capsule many employings soybean oil is auxiliary material, from the angle of health, too much edible vegetable oil easily causes human body Hyperlipemia, form the diseases such as hyperlipidemia and hypertension, it is auxiliary material that the present invention chooses high-quality linseed oil, its a large amount of leukotrienes contained, linoleic acid have powerful effect to human body, avoid negative effect such as fat accumulation, Hyperlipemia that other vegetable and animals oils are brought.
Content of the present invention is suspendible feed liquid, can be passed through batching, pelleting, drying, washes the operations such as ball and make soft capsule, produce the weight-losing soft capsules food that content content is 500mg-750mg/ grain.Described flexible glue utricule is by preparations such as gelatin, glycerine, water.The concrete preparation technology of soft capsule of the present invention belongs to prior art, repeats no more.
Usage of the present invention and consumption are: adult's recommended amounts every day is 1000mg/60kg.BW.Be every day 2 times by human body recommended intake, each 1-2 grain, imitated for the purpose of 15 days, can long-term taking.Through 390 example tests, effect of weight reducing is obvious, non-evident effect, taking convenience.
Raw material composition of the present invention is simple, rationally, composition is natural, and proportioning is appropriate, taking convenience, and effect of weight reducing is obvious, non-evident effect.The present invention has the synergy of too many levels, many target position, not only has antiobesity action, simultaneously can reducing blood lipid, raising immunity, protection cardiovascular and cerebrovascular etc.It is the green health care food of high fat of blood, constipation, obese patient.
Embodiment 1: a kind of slimming health food, is made up of flexible glue utricule and content, and its content proportioning is 6% CLA, 7% LBP-X, 12% licorice, 10% green-tea extract, and all the other are auxiliary material, is prepared into soft capsule 1000mg/ grain.The weight ratio of described flexible glue utricule and described content is 1: 3.
Embodiment 2: a kind of slimming health food, is made up of flexible glue utricule and content, and its content proportioning is 10% CLA, 13% LBP-X, 16% licorice, 12% green-tea extract, and all the other are auxiliary material.Be prepared into soft capsule 1000mg/ grain.The weight ratio of described flexible glue utricule and described content is 1: 3.
Embodiment 3: a kind of slimming health food, is made up of flexible glue utricule and content, and its content proportioning is 14% CLA, 7% LBP-X, 18% licorice, 13% green-tea extract, and all the other are auxiliary material.Be prepared into soft capsule 1000mg/ grain.The weight ratio of described flexible glue utricule and described content is 1: 3.
Embodiment 4: a kind of slimming health food, is made up of flexible glue utricule and content.Its content proportioning is 6% CLA, 15% LBP-X, 12% licorice, 20% green-tea extract, and all the other are auxiliary material.Be prepared into soft capsule 1000mg/ grain.The weight ratio of described flexible glue utricule and described content is 1: 3.
The present invention has carried out animal experiment to product prepared by described embodiment 1-4, proves that it has the function of Weight-reducing health.Be described as follows.
Soft gel products prepared by 1.1 samples: embodiment 1-4.Adult's recommended amounts every day is 1000mg/60kg.BW.Solvent preparation tested material is made with edible vegetable oil.
1.2 animals used as test: the male mice in kunming provided by Traditional Chinese Medicine Research Institute, Sichuan Province Experimental Animal Center 90, experimental animal room is SPF level, and use production licence number for the real dynamic pipe 043 in river, temperature is 20-25 DEG C, relative humidity 40%-70%.
1.3 dosage choice: animal subject establishes 333mg/kg.BW tri-dosage groups (being equivalent to 20 times of human dose).Respectively with Refrigerator store after edible vegetable oil to 250ml mixing, be finished and join again.Separately establish negative control group and model control group.Tested material gives animal in gavage mode, every day gavage once, gavage amount is 0.5ml/100g.bw, continuous 30 days.
1.4 instruments and material: disscting instrument, balance.Nutrient fodder: basal feed 80%, lard 10%, yolk powder 10%.
1.5 experimental techniques: from on-test, model control group, four embodiments all give nutrient fodder, blank treated animal gives the basal feed of equivalent, each dosage group gavage gives tested material, blank group, model control group give isopyknic vegetable oil, every day gavage once, continuous 30 days.Weigh in when the food-intake of duration of test record every animal, surplus appetite, off-test, cut open the belly and get body fat and weigh, calculate body/fat ratio.
The statistics of 1.6 experimental datas: experimental data adopts the process of SPSS 11.0 for windows software kit.The data of control group and dosage group are through homogeneity test of variance, and variance is neat, carries out variance analysis, as P value is less than 0.05, then compares between two by Dunnett method; If heterogeneity of variance, then carry out data conversion, still uneven, use rank test instead, as P value is less than 0.05, then compare between two by Dunnett sT3 method.Model control group and negative control group adopt T to check.
1.7 experimental results:
Product on the impact of Mouse Weight in table 1.
On the impact of Mouse Weight, (x puts down table 1 product
+s)
From table 1: the original body mass of three dosage group mouse is compared with negative control group, model control group, through statistical procedures, variance neat (P>0.05), and the results of analysis of variance (P>0.05), illustrate that the original body mass between them is balanced.Body weight at the end of three Dose Groups Study compares with model control group, through statistical procedures, all has significant difference (P < 0.05).The continued weight of duration of test three dosage treated animals reduces, and has no each dosage treated animal and occurs diarrhoea phenomenon.Meanwhile, according to the contrast of four embodiments, can find out changes of weight maximum be embodiment 3.
Product on the impact of mouse food-intake and food utilization in table 2.
Table 2 product is on the impact of mouse food-intake and food utilization
As can be seen from Table 2, each embodiment animal feed combines food utilization compared with model control group, there was no significant difference (P>0.05).
Product on the impact of animal body fat weight and fat/body ratio in table 3.
Table 3 product is on the impact of animal body fat weight and fat/body ratio
As can be seen from Table 3, after model control group animal experiment, animal body fat weight, fat/body ratio are all apparently higher than blank group, and difference all has conspicuousness (P < 0.01).After embodiment 3 animal experiment, body fat weight, fat/body ratio significantly reduce with model control group, and difference has conspicuousness (P < 0.05).
1.8 brief summaries: under this experiment condition, with the present embodiment to rat oral gavage 30 days, test opisthosoma weight, body weight total augment weight are all lower than model control group, after test, body fat weight, fat/body ratio are starkly lower than model control group, and difference has conspicuousness (P < 0.05 or P < 0.01).Each dosage treated animal food utilization compares with model control group, no significant difference (P > 0.05).This product is pointed out to have weight losing function to animal, especially obvious with embodiment 3.
Claims (3)
1. a slimming health food, be made up of flexible glue utricule and content, it is characterized in that: described content is made up of CLA, LBP-X, licorice, green-tea extract, auxiliary material, the percentage by weight of each component is: CLA 6%-14%, LBP-X 7%-18%, licorice 12%-19%, green-tea extract 10%-22%, auxiliary material 30%-65%.
2. according to the slimming health food described in claim 1, it is characterized in that: the percentage by weight of each component of described content is: CLA 10%, LBP-X 13%, licorice 16%, green-tea extract 12%, auxiliary material 49%.
3. according to the slimming health food described in claim 1, it is characterized in that: described auxiliary material is made up of linseed oil, phosphatide, beeswax, the percentage by weight of described linseed oil in content is 22%-57%, and phosphatide is 2%-7%, and beeswax is 2%-7%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410786206.1A CN104397538A (en) | 2014-12-18 | 2014-12-18 | Health-care diet food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410786206.1A CN104397538A (en) | 2014-12-18 | 2014-12-18 | Health-care diet food |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104397538A true CN104397538A (en) | 2015-03-11 |
Family
ID=52635260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410786206.1A Pending CN104397538A (en) | 2014-12-18 | 2014-12-18 | Health-care diet food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104397538A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105685288A (en) * | 2016-01-20 | 2016-06-22 | 广州丹奇日用化工厂有限公司 | Tea leaf composition and application of tea leaf composition |
| CN106262883A (en) * | 2016-08-02 | 2017-01-04 | 刘永潇 | A kind of Folium Bambusae soft polyphenol capsule and preparation method thereof |
| CN106418526A (en) * | 2016-12-20 | 2017-02-22 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid type multifunctional food capable of reducing blood lipid and reducing weight |
| CN106615228A (en) * | 2016-12-20 | 2017-05-10 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid-enriched diet blend oil and preparation method thereof |
| CN107981351A (en) * | 2017-12-19 | 2018-05-04 | 张开良 | A kind of meals microcapsule granule for adjusting body fat rate and preparation method thereof |
| CN113854559A (en) * | 2021-09-23 | 2021-12-31 | 营养屋(成都)生物医药有限公司 | Weight-losing health food and preparation method thereof |
| WO2022235818A3 (en) * | 2021-05-04 | 2022-12-22 | Virginia Tech Intellectual Properties, Inc. | Conjugated linoleic acid supplementation for disease treatment |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1335142A (en) * | 2000-07-26 | 2002-02-13 | 雷学军 | Weight reducing water containing natural medicinal component and its prepn |
| CN1342417A (en) * | 2001-10-08 | 2002-04-03 | 上海绿谷（集团）有限公司 | Health-care food containing wolfberry fruit extract and its preparing process |
| CN102018832A (en) * | 2010-11-16 | 2011-04-20 | 北京康比特体育科技股份有限公司 | Weight-reducing composition and preparation method thereof |
| CN102170798A (en) * | 2008-10-03 | 2011-08-31 | 西格马食品可变资本有限公司 | Composition for promoting control of total and LDL cholesterol and/or weight loss and/or thermogenesis |
| CN102188565A (en) * | 2011-04-09 | 2011-09-21 | 荣成百合生物技术有限公司 | Weight-losing soft capsules and preparation method thereof |
| CN103444928A (en) * | 2013-08-08 | 2013-12-18 | 贵州黔缘茶业有限责任公司 | Morning tea bag for health preservation in spring |
| CN103609783A (en) * | 2013-11-22 | 2014-03-05 | 丽江格林斯通食品有限公司 | Phyllanthus emblica compound tea and preparation method thereof |
-
2014
- 2014-12-18 CN CN201410786206.1A patent/CN104397538A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1335142A (en) * | 2000-07-26 | 2002-02-13 | 雷学军 | Weight reducing water containing natural medicinal component and its prepn |
| CN1342417A (en) * | 2001-10-08 | 2002-04-03 | 上海绿谷（集团）有限公司 | Health-care food containing wolfberry fruit extract and its preparing process |
| CN102170798A (en) * | 2008-10-03 | 2011-08-31 | 西格马食品可变资本有限公司 | Composition for promoting control of total and LDL cholesterol and/or weight loss and/or thermogenesis |
| CN102018832A (en) * | 2010-11-16 | 2011-04-20 | 北京康比特体育科技股份有限公司 | Weight-reducing composition and preparation method thereof |
| CN102188565A (en) * | 2011-04-09 | 2011-09-21 | 荣成百合生物技术有限公司 | Weight-losing soft capsules and preparation method thereof |
| CN103444928A (en) * | 2013-08-08 | 2013-12-18 | 贵州黔缘茶业有限责任公司 | Morning tea bag for health preservation in spring |
| CN103609783A (en) * | 2013-11-22 | 2014-03-05 | 丽江格林斯通食品有限公司 | Phyllanthus emblica compound tea and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 王要军 等: "《高级临床医学》", 30 September 2008, 内蒙古科学技术出版社 * |
| 裴轶琨: "沙棘油软胶囊辅助降血脂功能研究", 《中国油脂》 * |
| 闻茂 等: "沙棘黄酮软胶囊制备工艺的研究", 《内蒙古石油化工》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105685288A (en) * | 2016-01-20 | 2016-06-22 | 广州丹奇日用化工厂有限公司 | Tea leaf composition and application of tea leaf composition |
| CN106262883A (en) * | 2016-08-02 | 2017-01-04 | 刘永潇 | A kind of Folium Bambusae soft polyphenol capsule and preparation method thereof |
| CN106418526A (en) * | 2016-12-20 | 2017-02-22 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid type multifunctional food capable of reducing blood lipid and reducing weight |
| CN106615228A (en) * | 2016-12-20 | 2017-05-10 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid-enriched diet blend oil and preparation method thereof |
| CN107981351A (en) * | 2017-12-19 | 2018-05-04 | 张开良 | A kind of meals microcapsule granule for adjusting body fat rate and preparation method thereof |
| WO2022235818A3 (en) * | 2021-05-04 | 2022-12-22 | Virginia Tech Intellectual Properties, Inc. | Conjugated linoleic acid supplementation for disease treatment |
| CN113854559A (en) * | 2021-09-23 | 2021-12-31 | 营养屋(成都)生物医药有限公司 | Weight-losing health food and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103141712B (en) | Compound feed for laying hens in egg producing period and preparation method of feed | |
| CN106234926B (en) | Selenium-rich five cereals nutrient instant powder and preparation method thereof | |
| CN101695376B (en) | Health-care food for preventing diabetes | |
| CN104397538A (en) | Health-care diet food | |
| CN102940148B (en) | Daily ration for laying hen in middle and later egg laying periods and traditional Chinese medicine feed additive thereof | |
| CN103039745B (en) | Daily ration concentrated feed of egg-laying sheldrake and preparation method thereof | |
| CN102178100B (en) | Low-tryptophan feed for hybrid chicken and preparation method of the low-tryptophan feed | |
| CN102940155B (en) | Duckling feed for cherry valley duck and preparation method thereof | |
| CN101253903B (en) | Health food with fat-reducing function and its preparation | |
| CN104082540B (en) | Health-care eggs feed | |
| CN102172269B (en) | Hidegelatin fabricated food with beautification function | |
| CN103141709A (en) | Carp feed and preparation method thereof | |
| CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
| CN101327015B (en) | Bone-tonifying growth-encouraging rice flour | |
| CN106418501A (en) | Healthcare food with weight reducing function | |
| CN101884783A (en) | Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof | |
| CN1669464A (en) | Gastrodia tuber noodle and making method thereof | |
| CN105919089A (en) | Health-preserving chewable tablet compound capable of reducing blood lipid and reducing blood glucose as well as preparation method thereof | |
| CN104544084B (en) | A kind of health food for diabetics | |
| CN104082539B (en) | Health-care eggs additive | |
| CN103920140B (en) | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation | |
| CN104432068A (en) | Weight-losing health food | |
| CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
| CN103815080A (en) | Instant fagopyrm tataricum(Linn)gaench tea and preparation method for same | |
| CN105815738A (en) | Product assisting in lowering blood glucose and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150311 |
|
| RJ01 | Rejection of invention patent application after publication |